Back to Search
Start Over
Enteris BioPharma Publishes White Paper Examining Factors to Consider While Evaluating Oral Administration of Peptides
- Source :
- Plus Company Updates. September 13, 2022
- Publication Year :
- 2022
-
Abstract
- BOONTON: Enteris BioPharma, Inc. has issued the following news release: Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary [...]
- Subjects :
- Biological products industry
Peptides
General interest
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.717568951